Alkem Laboratories Ltd
BSE:539523
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alkem Laboratories Ltd
BSE:539523
|
IN |
|
China Success Finance Group Holdings Ltd
HKEX:3623
|
HK |
|
Busan Industrial Co Ltd
KRX:011390
|
KR |
|
S
|
Stereotaxis Inc
AMEX:STXS
|
US |
|
GIFT Holdings Inc
TSE:9279
|
JP |
|
S
|
Stille AB
STO:STIL
|
SE |
|
Compania Minera Autlan SAB de CV
BMV:AUTLANB
|
MX |
|
Wickes Group PLC
LSE:WIX
|
UK |
|
B
|
Belships ASA
XBER:NS6
|
NO |
|
A
|
Ashford Inc
AMEX:AINC
|
US |
|
R
|
ReWay Group SpA
MIL:RWY
|
IT |
|
Vector Ltd
NZX:VCT
|
NZ |
Wall Street
Price Targets
ALKEM Price Targets Summary
Alkem Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
ALKEM
is 5 954.07 INR
with a low forecast of 4 394.22 INR and a high forecast of 7 243.18 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ALKEM's stock price target?
Price Target
5 954.07
INR
According to Wall Street analysts, the average 1-year price target for
ALKEM
is 5 954.07 INR
with a low forecast of 4 394.22 INR and a high forecast of 7 243.18 INR.
What is Alkem Laboratories Ltd's Revenue forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Alkem Laboratories Ltd's revenue is
15%.
The projected
CAGR
for the next 3 years is
12%.
What is Alkem Laboratories Ltd's Operating Income forecast?
Projected CAGR
17%
For the last 13 years the
compound annual growth rate for
Alkem Laboratories Ltd's operating income is
15%.
The projected
CAGR
for the next 3 years is
17%.
What is Alkem Laboratories Ltd's Net Income forecast?
Projected CAGR
7%
For the last 13 years the
compound annual growth rate for
Alkem Laboratories Ltd's net income is
14%.
The projected
CAGR
for the next 3 years is
7%.
